Federal health regulators said Monday that the drugmaker Pfizer has agreed to pull a leukemia drug off the market after a follow-up study showed it failed to slow the disease.
FDA: Pfizer will pull ineffective leukemia drug
Seeded on Mon Jun 21, 2010 4:37 PM EDT (msnbc.com)
— Filed under: health, cancer, corporate-news, products-and-services, diseases-and-conditions, medical-research, clinical-trials


No surprises here. A drug rushed to market under an accelerated approval process, then years later, "oops, doesn't work like we thought and guess what actually caused some deaths" Silly us, back to the old drawing board we go...